ResearcherUniversity Hospital Schleswig-HolsteinActive in the last 2 years
Claudia Geismann
Matched on ORCID iD 0000-0003-0640-9256; OpenAlex author ID A5051461226. Sources: OpenAlex.
Their work
- Papers
- 10
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 10
- Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Functional Link to Phenotype Heterogeneity. Co-author DOI 10.3390/ijms26115398↗
- NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer. Co-author DOI 10.1038/s41419-022-05535-9↗
- Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby P… Co-author DOI 10.3390/antiox12101818↗
- Get rid of pancreatic cancer by inhibiting garbage disposal?: Comment on "UAE1 Inhibition mediates the unfolded protein response, DNA damage and caspase-depend… Co-author DOI 10.1016/j.tranon.2020.100968↗
- Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Co-author DOI 10.3390/cells9112353↗
- NF-κB Dependent Chemokine Signaling in Pancreatic Cancer. Co-author DOI 10.3390/cancers11101445↗
- TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines. Co-author DOI 10.3390/ijms19061661↗
- Role of CCL20 mediated immune cell recruitment in NF-κB mediated TRAIL resistance of pancreatic cancer. Co-author DOI 10.1016/j.bbamcr.2017.02.005↗
- c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. Co-author DOI 10.1038/cddis.2014.417↗
- Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased protea… Co-author DOI 10.1038/onc.2012.493↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander Arlt · 8 shared papers, 2013–2023 · strength 1.01
- Paper Get rid of pancreatic cancer by inhibiting garbage disposal?: Comment on "UAE1 Inhibition mediates the unfolded protein… DOI 10.1016/j.tranon.2020.100968↗
- Paper Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. DOI 10.3390/cells9112353↗
- Paper NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer. DOI 10.1038/s41419-022-05535-9↗
- H. Schäfer · 8 shared papers, 2013–2025 · strength 0.96
- Paper Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Fun… DOI 10.3390/ijms26115398↗
- Paper Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative St… DOI 10.3390/antiox12101818↗
- Paper NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer. DOI 10.1038/s41419-022-05535-9↗
- Susanne Sebens · 4 shared papers, 2013–2025 · strength 0.53
- Paper Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Fun… DOI 10.3390/ijms26115398↗
- Paper Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative St… DOI 10.3390/antiox12101818↗
- Paper Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptib… DOI 10.1038/onc.2012.493↗
- Anna Trauzold · 3 shared papers, 2014–2025 · strength 0.50
- Paper Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma-A Fun… DOI 10.3390/ijms26115398↗
- Paper Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative St… DOI 10.3390/antiox12101818↗
- Paper c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells. DOI 10.1038/cddis.2014.417↗
- Günter Schneider · 5 shared papers, 2014–2023 · strength 0.46
- Paper NF-κB/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer. DOI 10.1038/s41419-022-05535-9↗
- Paper NF-κB Dependent Chemokine Signaling in Pancreatic Cancer. DOI 10.3390/cancers11101445↗
- Paper TRAIL/NF-κB/CX3CL1 Mediated Onco-Immuno Crosstalk Leading to TRAIL Resistance of Pancreatic Cancer Cell Lines. DOI 10.3390/ijms19061661↗
- Christoph Röcken · 2 shared papers, 2023–2025 · strength 0.43
- Jan-Paul Gundlach · 2 shared papers, 2019–2023 · strength 0.27
- Dinara M. Baiskhanova · 1 shared paper, 2025 · strength 0.27
- Nourhane Ammar · 1 shared paper, 2023 · strength 0.19
- Christian Röder · 1 shared paper, 2023 · strength 0.19
- Christian Schneeweis · 1 shared paper, 2023 · strength 0.17
- Bence Sipos · 2 shared papers, 2014–2017 · strength 0.09
- Karen Legler · 1 shared paper, 2017 · strength 0.06
- Zonera Hassan · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.